Clinical observation study of ARB (Olmesartan) for the hypertensive patients with heart failure

Clinical observation study of ARB (Olmesartan) for the hypertensive patients with heart failure - Clinical observation study of ARB (Olmesartan) for the hypertensive patients with heart failure

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011804

Enrollment

Registered

2013-10-01

Start date

2013-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive patients with heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertensive patients who meed to be administered ARB(sBP>129mmHg or dBP>84mmHg) NT-proBNP>124pg/ml

Exclusion criteria

Exclusion criteria: The patients who have begun to take the other renin-angiotensin system inhibitors newly within one month sBP>179mmHg or dBP>109mmHg The patients who have atrial fibrillation or frequent premature beats eGFR<30, the patients on hemodialysis or peritoneal dialysis, hyperkalemia The patients who were judged to be inappropriate by the chief researcher

Design outcomes

Primary

Measure	Time frame
Change of the heart autonomic nerve function after the treatment	—

Countries

Japan

Contacts

Public ContactShohei Ishikawa

Kagawa university hospital cardiovascular medicine

noma@kms.ac.jp087-898-5111

Outcome results